ClinicalTrials.gg
Sign In

Bursitis clinical trials

The registry lists 383 studies for Bursitis across more than 10 countries. 111 are recruiting or about to start. 345 of them are mainly about Bursitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Bursitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
193
Recruiting
64
Not yet recruiting
43
Status unknown
39
Terminated
16
Active, not recruiting
16

Phase

Phase 4
22
Phase 2
18
Phase 3
16
Phase 1
5
Early Phase 1
2

Where

Pakistan
86
Turkey
59
United States
45
Taiwan
37
Egypt
23
Korea, Republic of
15

Who runs them

Riphah International University (52) · Cairo University (11) · Superior University (8) · Foundation University Islamabad (8) · Shin Kong Wu Ho-Su Memorial Hospital (7) · National Taiwan University Hospital (7) · Taipei Veterans General Hospital, Taiwan (7) · Istanbul University - Cerrahpasa (6)

What is being tested here

Drugs under test in Bursitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Methylprednisolone113
Platelet rich plasma102
Etodolac101
Meloxicam101
Losartan101
Bevacizumab101
Triamcinolone Acetonide018
Triamcinolone018
Hyaluronic Acid003
Microbial Collagenase003

Drug classes tested here Corticosteroids 1 open · NSAIDs 1 open · Local anesthetics 4

Coming up

1phase 3 study under way
37studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 64 Bursitis studies recruiting now, 17 (27%) set no upper age limit and 40 (63%) stop at 75 or younger. 0 (0%) take children under 18. 4 (6%) are for women only and 0 (0%) for men only; 8 (13%) take healthy volunteers.

Recruiting studies that take each age, of 64
AgeWomenMen
100 (0%)0 (0%)
1827 (42%)26 (41%)
3034 (53%)33 (52%)
4059 (92%)55 (86%)
5063 (98%)59 (92%)
6547 (73%)45 (70%)
7528 (44%)26 (41%)
8520 (31%)18 (28%)

Across all 383 studies, recruiting or not: 62% stop at 75 or younger and 43% at 65; 3% take children; 4% are for women only and 0% for men only; 12% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Bursitis studies take

Of 217 interventional studies with no phase under Bursitis, half reached primary completion within 10 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase10 mo5–17 · 217 studies—10 mo5–17 · 217 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting1

Newly registered7

Show 2 more

Studies

Recruiting first, then most recently updated. Showing 50 of 383. Browse all 383 → or search them.